79342589 - ASTARTZ

Information

• Trademark
• 79342589

• Source

• Serial Number

  79342589

• Registration Number

  7141339

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto
  • 45 - Legal services

• Filing Date

  February 25, 2022
  2 years ago

• Registration Date

  August 22, 2023
  9 months ago

• Transaction Date

  May 10, 2024
  16 days ago

• Status Date

  August 22, 2023
  9 months ago

• Published for Opposition Date

  June 06, 2023
  11 months ago

• Location Date

  May 10, 2024
  16 days ago

• Status Code

  700

• Current Location

  TMEG LAW OFFICE 104

  Employee Name

  EISNACH, MICHAEL PATRI

• Attorney Docket Number

  0332004

  Attorney Name

  M. Scott Alprin

  Law Office Assigned Location Code

  L40

• Owners

  • Nihon Medi-Physics Co., Ltd.

Case File Statements

• GS0401: Custom manufacture of pharmaceuticals; custom manufacture of investigational new drug; custom manufacture of radiopharmaceuticals; custom synthesis of labeled compound; custom manufacture of peptides; custom manufacture of antibodies; custom manufacture of proteins; custom protein modification; custom antibody modification; custom extraction of pharmaceuticals and veterinary preparations; custom synthesis and refining of pharmaceuticals and veterinary preparations; custom peptide synthesis services; custom synthesis and refining of pharmaceuticals consisting of antibodies; custom manufacture of pharmaceuticals consisting of antibodies; custom synthesis and refining of pharmaceuticals consisting of antibody fragments; custom manufacture of pharmaceuticals consisting of antibody fragments; custom synthesis and refining of pharmaceuticals consisting of antibody derivatives; custom manufacture of pharmaceuticals consisting of antibody derivatives; custom radioactive labeling of antibodies; custom radioactive labeling of antibody fragments; custom radioactive labeling of antibody derivatives; custom radioactive labeling of peptides
• DM0000: The mark consists of the Greek letter "alpha" before the term "STARTZ" appearing as one word in stylized format.
• B00001: In the statement, line 56 and 57, " The mark consists of the Greek letter alpha plus the term "STARTZ" appearing as "aSTARTZ" and pronounced as "alphaSTARTZ," in stylized format." should be deleted, and "The mark consists of the Greek letter "alpha" before the term "STARTZ" appearing as one word in stylized format." should be inserted.
• GS0051: Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the diagnosis of cancer; chemical reagents for medical purposes; medical diagnostic reagents; radioactive substances for medical purposes; isotopes for medical purposes; radioisotope markers for therapeutic or diagnostic use; radioactive pharmaceutical preparations for in vivo diagnostics or therapeutic use; synthetic peptides for pharmaceutical purposes for the treatment of cancer; synthetic peptides for pharmaceutical purposes for the diagnosis of cancer; pharmaceuticals consisting of antibodies for the treatment of cancer; pharmaceuticals consisting of antibodies for the diagnosis of cancer; pharmaceuticals consisting of antibody fragments for the treatment of cancer; pharmaceuticals consisting of antibody fragments for the diagnosis of cancer; pharmaceuticals consisting of antibody derivatives for the treatment of cancer; pharmaceuticals consisting of antibody derivatives for the diagnosis of cancer; antibodies for medical purposes
• GS0011: Industrial chemicals; chemical preparations for scientific purposes; diagnostic reagents for scientific or research use; chemicals for use in the manufacture of pharmaceuticals; chemicals for use in the manufacture of radiopharmaceuticals; radioactive elements for scientific purposes; isotopes for industrial purposes; peptide substrates for scientific purposes; peptide for use in the manufacture of pharmaceuticals; chelating agents for use in the manufacture of pharmaceuticals; polypeptides for scientific purposes; antibodies for scientific purposes, other than for medical or veterinary use; chelate compound; organic chelating agents; metal chelating agents
• GS0451: Granting of licenses to others for the use of intellectual property; legal services, namely, exploitation of industrial property rights
• GS0421: Research and development of medicines; testing, inspection or research services in the fields of pharmaceuticals; advisory, consultancy and providing information relating to testing, inspection or research services in the fields of pharmaceuticals; development of pharmaceuticals; advisory, consultancy and providing information relating to development of pharmaceuticals; conducting clinical trials for pharmaceuticals for others; advisory, consultancy and providing information relating to clinical trials for pharmaceuticals; research and development of radiopharmaceuticals; development of radiopharmaceuticals; advisory, consultancy and providing information relating to development of radiopharmaceuticals; research and development services relating to peptides; research and development services in the field of antibodies; research and development services relating to peptide labeling by radioactive substances; research and development services relating to antibody labeling by radioactive substances

Case File Event Statements

• 6/16/2022 - a year ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 6/22/2022 - a year ago

  2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI

• 6/23/2022 - a year ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/28/2022 - a year ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 9/30/2022 - a year ago

  5 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP

• 12/9/2022 - a year ago

  6 - ASSIGNED TO EXAMINER Type: DOCK

• 12/19/2022 - a year ago

  7 - NON-FINAL ACTION WRITTEN Type: CNRT

• 12/20/2022 - a year ago

  8 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 2/15/2023 - a year ago

  9 - REFUSAL PROCESSED BY MPU Type: RFRR

• 2/15/2023 - a year ago

  10 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 3/6/2023 - a year ago

  11 - REFUSAL PROCESSED BY IB Type: RFNT

• 4/17/2023 - a year ago

  12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/17/2023 - a year ago

  13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/18/2023 - a year ago

  14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 4/19/2023 - a year ago

  15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 4/22/2023 - a year ago

  16 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA

• 4/25/2023 - a year ago

  17 - WITHDRAWN FROM PUB - MANAGING ATTORNEY REQUEST Type: PBMR

• 4/26/2023 - a year ago

  18 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 5/1/2023 - a year ago

  19 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 5/1/2023 - a year ago

  20 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 5/1/2023 - a year ago

  21 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 5/1/2023 - a year ago

  22 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 5/1/2023 - a year ago

  23 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 5/15/2023 - a year ago

  24 - ASSIGNED TO PETITION STAFF Type: APET

• 5/17/2023 - a year ago

  25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 5/17/2023 - a year ago

  26 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 5/17/2023 - a year ago

  27 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 6/6/2023 - 11 months ago

  28 - PUBLISHED FOR OPPOSITION Type: PUBO

• 6/6/2023 - 11 months ago

  29 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 6/6/2023 - 11 months ago

  30 - CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED Type: CHPB

• 6/6/2023 - 11 months ago

  31 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 8/22/2023 - 9 months ago

  32 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 8/22/2023 - 9 months ago

  33 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 8/28/2023 - 9 months ago

  34 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R

• 11/22/2023 - 6 months ago

  35 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 11/27/2023 - 6 months ago

  36 - FINAL DISPOSITION PROCESSED Type: FIMP

• 11/27/2023 - 6 months ago

  37 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 12/19/2023 - 5 months ago

  38 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO

• 5/9/2024 - 17 days ago

  39 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE

• 5/10/2024 - 16 days ago

  40 - CORRECTION UNDER SECTION 7 - PROCESSED Type: COC.

• 5/10/2024 - 16 days ago

  41 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE